Myomo

The AI engine Fit Assessment

Beta

Myomo is a medical technology firm that specializes in developing myoelectric orthotics to assist individuals with neuromuscular disorders. Their flagship product, the MyoPro, is a lightweight, powered arm brace designed to restore mobility and function in patients with upper-limb paralysis.

Blurb

Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.

HQ Location

Cambridge (United States)

Founded

2004

Employees

51 - 200

Total funding raised

$55.12M

Funding Status

Post-IPO Debt, $12.50M, November 4, 2025
Subspaces
  • Rehabilitation Robotics

Myomo, Inc. is a medical device company specializing in myoelectric technology to enhance mobility for individuals with neurological disorders and upper-limb paralysis. We design and market the MyoPro®, a non-invasive, powered arm brace (orthosis) that helps people regain functional use of their arms and hands after a stroke, brachial plexus injury (BPI), traumatic brain injury (TBI), spinal cord injury, or conditions like multiple sclerosis (MS).



By detecting a user’s own muscle signals through sensors on the skin, the MyoPro® assists movement, empowering users to perform daily tasks and improve their quality of life. It is the only device of its kind that offers this capability using non-invasive technology.